Cardiac Implications of COVID-19 in Deceased and Recovered Patients: A Systematic Review

Rajaram Khanal1, Shreeyash Raj Bhattarai2, Kriti Basnet2

  • 1Department of Cardiology, Manmohan Cardiothoracic Vascular and Transplant Center, Kathmandu, Nepal.

Insights

Coronavirus disease 2019 (COVID-19) commonly causes cardiac complications, including heart failure and arrhythmias, leading to significant mortality. Early cardiac biomarker monitoring is crucial for prognosis in COVID-19 patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) primarily affects the respiratory system, but cardiac implications are significant.
  • Cardiac complications in COVID-19 patients are less understood compared to pulmonary issues.

Purpose of the Study:

  • To investigate and summarize the cardiac implications of COVID-19.
  • To highlight the association between COVID-19 and cardiovascular complications.

Main Methods:

  • A systematic literature search was conducted on PubMed, PubMed Central, and Google Scholar.
  • NHLBI Study Quality Assessment Tools were used to evaluate the risk of bias in observational and cross-sectional studies.

Main Results:

  • All 14 selected studies demonstrated high quality (score ≥9).
  • Cardiac complications are frequent in COVID-19 patients and are linked to increased mortality.
  • Pre-existing cardiovascular diseases and diabetes mellitus worsen prognosis in COVID-19 patients.
  • Elevated cardiac biomarkers (highly sensitive troponin I, creatinine, creatinine kinase-MB) on admission are indicative of poor prognosis.

Conclusions:

  • Common cardiac complications include heart failure, myocardial injury, and arrhythmias.
  • Continuous cardiac monitoring and prompt management of elevated cardiac markers are essential for COVID-19 patients.
  • Understanding cardiac involvement is critical for comprehensive COVID-19 patient care.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
31
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
27